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ABSTRACT 
Background: Diazepam, a highly lipid-soluble benzodiazepine, is commonly 
used as a sedative agent during and after surgery. Based on a literature search, 
no published data are available concerning diaphragmatic function (as mea- 
sured by contractility and electrical activity) during and after the administration 
of diazepam. 
Objective: The purpose of this study was to assess the effects of diazepam use 
on diaphragmatic function and recovery in pentobarbital-anesthetized dogs. 
Methods: This open-label, dose-finding, pharmacologic study was conducted 
at the Department of Anesthesiology, Institute of Clinical Medicine, University of 
Tsukuba, Tsukuba, Japan. Healthy adult mongrel dogs weighing 10 to 15 kg were as- 
signed to 1 of :3 study groups: low-dose (0.2-mg/kg) diazepam, high-dose (0.5-mg/kg) 
diazepam, or control (no study drug). Each dog was anesthetized with pento- 
barbital 2 mg/kg • h IV. Study drug was administered IV for 1 hour. Diaphragmatic 
function was assessed before (baseline) and at 0 (immediately after), 1, and 2 
hours after the end of study drug administration, using measurement of transdia- 
phragmatic pressure (Pdi), defined as the difference between gastric and esoph- 
ageal pressures, and by integrated electrical activity (20- and 100-Hz stimula- 
tion) of the crural (Edi-cru) and costal (Edi-cost) parts of the diaphragm. The 
percentage changes from baseline in Edi-cru (%Edi-cru) and Edi-cost (%Edi-cost) 
were calculated. 
Results: Twenty-four mongrel dogs were used in the study; 8 dogs were as- 
signed to each treatment group. During diazepam administration i the low-dose 
group, significant decreases from baseline in Pdi were found with 20-Hz stimu- 
lation (15.6 [1.7] vs 13.3 [1.9] cm H20; P < 0.05) and 100-Hz stimulation (22.0 
[2.1] vs 19.6 [1.8] cm H20; P < 0.05). In the high-dose group, the decreases in 
Pdi were significant with 20-Hz stimulation (15.5 [1.8] vs 10.0 [2.0] cm H20; 
P< 0.05) and 100-Hz stimulation (22.2 [1.9] vs 16.2 [2.0] cm H20; P< 0.05). In the 
low-dose group at 100-Hz stimulation, mean (SD) %Edi-cru and %Edi-cost were 
significantly lower compared with baseline (88.8% [6.6%] and 88.5% [5.9%], re- 
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spectively; both, P < 0.05). In the high-dose group at 100-Hz stimulation, mean 
(SD) %Edi-cru and %Edi-cost were significantly lower compared with baseline 
(77.5% [4.3%] and 78.0% [5.0%], respectively; both, P < 0.05). The decreases in 
Pdi, %Edi-crn, and %Edi-cost were significantly greater in the high-dose group 
compared with the low-dose group (all, P < 0.05). 
Conclusion: The results of this experimental study of the effects of diazepam 
on diaphragmatic function and recovery in pentobarbital-anesthetized dogs sug- 
gest that diazepam inhibits diaphragmatic function in a dose-related manner and 
delays recovery. (Curt Ther Res Clin Exp. 2005;66:401-408) Copyright © 2005 
Excerpta Medica, Inc. 
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INTRODUCTION 
The diaphragm is the most important inspiratory muscle in the respiratory 
pump. 1 In the past 20 years, the effects of commonly administered inhalational 
anesthetic agents (eg, enflurane, halothane, isoflurane, nitrous oxide, sevoflu- 
rane) on diaphragmatic function have been investigated. When used at clinical 
concentrations, nitrous oxide has not been found to affect diaphragmatic con- 
tractility. 2 In contrast, enflurane, 3 halothane, 3 4 isoflurane, 5 and sevoflurane 6 
have been shown to impair the contractile properties of the diaphragm. Like 
these volatile anesthetics, propofol, widely used for anesthesia nd sedation in 
patients undergoing diagnostic and therapeutic surgical procedures, has been 
found to decrease diaphragmatic contractility. 7 
Although most patients receive short-acting benzodiazepines (eg, midazolam) 
during and after surgery, diazepam, a highly lipid-soluble benzodiazepine with 
sedative and anxiolytic effects, is commonly used as a sedative agent) Seda- 
tion improves tolerability of tracheal intubation and extubation and invasive pro- 
cedures, facilitates mechanical ventilation, blunts excessive hemodynamic and 
metabolic responses, and allays anxiety. 9 Radell et al 9 found that prolonged 
mechanical ventilation with sedation and complete diaphragmatic inactivity cause 
a disturbance of diaphragmatic ontractility in vivo. 1° However, based on a 
MEDLINE search (key words: diazepam, benzodiazepine, diaphragm, and contrac- 
tility; years: 1978-2003), no published ata are available concerning diaphragmatic 
function during and after the administration of diazepam. 
In the present study, the effects of diazepam use on diaphragmatic function 
and recovery were examined in pentobarbital-anesthetized dogs. 
MATERIALS AND METHODS 
This open-label, dose-finding, pharmacologic study was conducted at the 
Department of Anesthesiology, Institute of Clinical Medicine, University of 
Tsukuba, Tsukuba, Japan. The protocol was approved by the animal research 
committee at the university, and the care of the animals was in accordance with 
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guidelines for ethical animal research at the University of Tsukuba. 2,7,n The 
author performed all measurements and analyses in the study. 
Animals 
Healthy adult mongrel dogs weighing 10 to 15 kg (provided by Animal Guidance 
Center, Mashiko, Japan) were studied. The dogs were randomly assigned, in a 1:1 
ratio using a computer-generated list of random numbers, to 1 of 3 study groups: 
low-dose (0.2-mg/kg) diazepam, high-dose (0.5-mg/kg) diazepam, or control (no 
study d rug). 
Anesthesia 
Animal preparation was similar to that described previously. 2,7,n Anesthesia 
was maintained using pentobarbital 2 mg/kg • h IV. No muscle relaxant was used. 
Each animal underwent tracheal intubation, and ventilation was mechanically 
controlled using a mixture of oxygen and air (fraction of inspired oxygen, 0.4) 
to maintain arterial pH 7.35 to 7.45, arterial partial pressure of oxygen >100 mm Hg, 
and arterial partial pressure of carbon dioxide 35 to 40 mm Hg. To monitor arte- 
rial blood pressure and administer maintenance fluid therapy and study drug, 
the right femoral artery and vein and left femoral vein, respectively, were can- 
nulated. Study drug was continuously administered IV for 1 hour with an elec- 
trical infusion pump. 
Assessment of Diaphragmatic Function and Recovery 
Diaphragmatic function was assessed before (baseline) and at 0 (immediately 
after), 1, and 2 hours after the end of study drug administration using contractil- 
ity 0e, measurement of transdiaphragmatic pressure [Pdi], defined as the dif- 
ference between gastric and esophageal pressures) and electrical activity 
(ie, measurement of integrated electrical activity of the diaphragm), as de- 
scribed previously. 2,7,11 Pdi was measured using 2 thin-walled latex balloons--one 
positioned in the stomach and the other positioned in the middle third of 
the esophagus. Balloons were connected to a differential pressure transducer 
(TP-604T, Nihon Koden, Tokyo, Japan) and an amplifier (model 1257, Nihondenki 
Sen-el, Tokyo, Japan). Phrenic nerves were exposed bilaterally at the neck, and 
stimulating electrodes were placed around them. Supramaximal e ectrical stimuli 
(10-15 V) of 0.1-ms duration were applied for 2 seconds at low (20-Hz) and high 
(100-Hz) frequency using an electrical stimulator (SEN-3301, Nihon Koden). 
Diaphragmatic contractility was evaluated by measuring the maximal Pdi gener- 
ated by test stimuli after airway occlusion at functional residual capacity. 
Electrical activity of the diaphragm was recorded using 2 pairs of fishhook elec- 
trodes, and its signal was rectified and integrated using an integrator with a time 
constant of 0.1 second. This signal was regarded as the integrated electrical activ- 
ity of the crural (Edi-cru) and costal (Edi-cost) parts of the diaphragm. 
Before the study drug was administered (baseline), the dogs were allowed to 
stabilize for at least 30 minutes, and then heart rate (HR), mean arterial pressure 
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(MAP), Pdi, Edi-cru, and Edi-cost were measured. These parameters were mea- 
sured again at 0, 1, and 2 hours after the end of study drug administration. 
Percentage changes from baseline in Edi-cru (%Edi-cru) and Edi-cost (%Edi-cost) 
were calculated. 2,u 
Statistical Analysis 
Statistical analyses were performed using analysis of variance for repeated 
measurements, followed by the Bonferroni-Dunn test for multiple comparisons 
and the Student test, where appropriate. P < 0.05 was considered statistically 
significant. Analyses were performed using SPSS version 8.0 (SPSS Inc., Chicago, 
Illinois). 
RESULTS 
Twenty-four dogs (14 males and 10 females; mean [SD] weight, 12.5 [1.5] kg; 
range, 10-15 kg) were included in the study; 8 dogs were assigned to each treat- 
ment group. No significant differences in baseline HR, MAP, Pdi, Edi-cru, and 
Edi-cost were observed between the 3 groups (Table). 
Immediately after diazepam administration in the low-dose group, signifi- 
cant decreases from baseline in mean (SD) HR (142 [10] vs 133 [11] bpm) and 
MAP (133 [10] vs 123 [8] mm Hg) were seen (both, P < 0.05). In the high- 
dose group, significant decreases in HR (140 [9] vs 121 [10] bpm) and MAP 
(131 [9] vs 113 [11] mm Fig) were seen (both, P< 0.05). In both groups, FiR and 
MAP returned to near-baseline values by 1 hour after the end of study drug 
administration. 
Immediately after diazepam administration i the low-dose group, significant 
decreases from baseline in Pdi with both 20-Hz stimulation (15.6 [1.7] vs 13.3 
[1.9] cm H20 ) and 100-Hz stimulation (22.0 [2.1] vs 19.6 [1.8] cm H20 ) were seen 
(both, P < 0.05). In the high-dose group, the decreases in Pdi with 20-Hz (15.5 
[1.8] vs 10.0 [2.0] cm H20 ) and 100-Hz stimulation (22.2 [1.9] vs 16.2 [2.0] cm 
H20 ) were also significant (both, P < 0.05). In the low-dose group at 100-Hz stim- 
ulation, significant decreases from baseline in both %Edi-cru (88.8% [6.6%]) and 
%Edi-cost (88.5% [5.9%]) were seen (both, P< 0.05). In the high-dose group, both 
%Edi-cru (77.5% [4.3%]) and %Edi-cost (78.0% [5.0%]) were also decreased sig- 
nificantly from baseline (both, P < 0.05). 
The decreases in Pdi at 20-Hz and 100-Hz stimulation and the decreases in 
Edi-cru and Edi-cost at 100-Hz stimulation were significantly greater in the high- 
dose compared with the low-dose group (all, P < 0.05). At 1 and 2 hours after 
the end of diazepam administration, these variables had not returned to near- 
baseline values. 
Immediately after diazepam administration, mean (SD) changes from base- 
line in HR were significantly greater in the low-dose group (-9 [2] bpm) and the 
high-dose group (-19 [5] bpm) compared with the control group (1 [1] bpm) 
(both, P < 0.05). Mean (SD) changes in MAP were also significantly greater in the 
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Table. Changes in hemodynamic characteristics, transdiaphragmatic pressure (Pdi), 
a nd integ rated electrical activity of the diaphragm in pentobarbital-anesthetized 
dogs (N = 24) before (baseline) and after diazepam administration. Values 
are presented as mean (SD). 
Parameter/Group Baseline 0 Hour* 1 Hour 
Recovery 
2 Hours 
Hemodynamic characteristics 
HR, bpm 
LD 142 (10) 133 (11) t* 142 (10) § 141 (10) § 
HD 140(9) 121 (10) t~ll  139(11)§ 140(12)§ 
CTL 140 (10) 141 (12) 1 40 (11 ) 140 (11) 
MAP, mm Hg 
LD 133 (10) 123 (8) t* 132 (10)§ 133 (11)§ 
HD 131 (9) 113 (11) t*ll 130(10)§ 131 (9)§ 
CTL 130(10) 131 (12) 131 (10) 130(9) 
Electrical activity 
Pdi, cm H20 
20-Hz stimulation 
LD 1S.6 (1.7) 13.3 (1.9) tI 13.S (1.9) tI 
HD 1S.S (1.8) 10.0 (2.0)¢*11 9.9 (1.8)¢*11 
CTL 15.5 (1.6) 15.3 (1.6) 15.2 (1.4) 
100-Hz stimulation 
LD 22.0 (2.1) 19.6 (1.8) t* 19.5 (2.0) t* 
HD 22.2 (1.9) 16.2 (2.0) t*ll 16.3 (1.8) t*ll 
CTL 22.4 (2.0) 22.1 (I .6) 22.3 (I .4) 
%Edi-cru 
20-Hz stimulation 
LD 1 00.0 (0.0) 98.8 (10.4) 98.5 (4.2) 
HD 1 00.0 (0.0) 99.1 (4.8) 99.5 (3.8) 
CTL 1 00.0 (0.0) 100.1 (6.7) 100.1 (6.7) 
100-Hz stimulation 
LD 1 00.0 (0.0) 88.8 (6.6) t* 89.6 (7.7) t* 
HD 1 00.0 (0.0) 77.3 (4.3) t~ll 78.0 (S.0) t~ll 
CTL 1 00.0 (0.0) 100.0 (2.7) 100.0 (2.7) 
13.s (1.87* 
10.1 (1.9) t~ll 
lS.4 (1 .s) 
19.S (2.0) t* 
16.3 (2.0) t*ll 
22.2 (1.8) 
98.8 (10.4) 
99.5 (3.8) 
1 00.1 (6.7) 
89.6 (7.7) t* 
78.0 (S.O) t*ll 
1 oo.o (o.o) 
(continued) 
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Table. (Continued) 
Recovery 
Parameter/Group Baseline 0 Hour* 1 Hour 2 Hours 
%Edi-cost 
20-Hz stimulation 
LD 100.0 (0.0) 98.5 (4.2) 98.8 (1 0.4) 98.8 (10.4) 
HD 100.0 (0.0) 99.5 (3.8) 99.5 (3.8) 99.5 (3.8) 
CTL 100.0 (0.0) 100.1 (6.7) 100.0 (0.0) 100.0 (0.0) 
1 00-Hz stimulation 
LD 100.0 (0.0) 88.5 (5.9) t* 89.0 (8.3) t* 89.0 (8.3) t* 
HD 100.0 (0.0) 78.0 (5.0)¢*" 77.8 (6.1)¢*" 77.8 (6.1)¢*" 
CTL 100.0 (0.0) 100.1 (6.7) 100.0 (0.0) 100.1 (6.7) 
HR = heart rate; LD = low-dose diazepam group; HD = high-dose diazepam group; CTL = control 
group; MAP = mean arterial pressure; %Edi-cru = percentage of integrated electrical activity of the 
crural part of diaphragm; %Edi-cost = percentage of integrated electrical activity of the costal part of 
diaphragm. 
*Immediately after the end of study drug administration. 
tp < 0.05 versus baseline. 
~P < 0.05 versus control group. 
§P < 0.05 versus 0 hour. 
lip < 0.05 versus LD group. 
low-dose group @10 [3] mm Hg) and high-dose group (-18 [4] mm Hg) com- 
pared with the control group (1 [ 1 ] mm Hg) (both, P < 0.05/. 
Immediately after diazepam administration, mean (SD) decreases in Pdi at 
20-Hz stimulation were significantly greater in the low-dose group (2.3 [0.6] 
cm H20 ) and high-dose group (5.5 [1.4] cm H20 ) compared with the control 
group (0.2 [0.1] cm H20 ) (both, P < 0.05/. The mean (SD) decreases in Pdi at 
100-Hz stimulation were also significantly greater in the low-dose group 
(2.4 [0.6] cm H20 ) and high-dose group (6.0 [1.4] cm H20 ) compared with the 
control group (0.3 [0.1] cm H20 ). The mean changes remained significantly 
greater in the 2 treatment groups compared with the control group at both 
20-Hz and 100-Hz stimulation at 1 and 2 hours after the end of diazepam infusion 
(all, P < 0.051. 
At 100-Hz stimulation, %Edi-cru was significantly greater in the low-dose 
group (,,11.2% [2.9%]) and the high-dose group (-22.5% [5.6%]1 compared 
with the control group (0.0% [0.1%]1. Similarly, at 100-Hz stimulation, %Edi- 
cost was significantly greater in the low-dose group (-11.5% [3.0%]) and high- 
dose group (--22.0% [5.4%]/compared with the control group (0.1% [0.1%]). 
The differences remained significant at 1 and 2 hours after the end of diaze- 
pam infusion. 
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DISCUSSION 
Because the dogs were anesthetized with pentobarbital, the combined effects 
of pentobarbital and diazepam on diaphragmatic function (contractility and 
electrical activity) were examined in the present study. However, it has been 
reported that the pentobarbital dosage (2 mg/kg • h) used in this study does not 
affect diaphragmatic function, G a finding in accordance with the results of the 
present study, in which no significant changes in Pdi, Edi-cru, or Edi-cost were 
found in pentobarbital-anesthetized dogs receiving no study drug (control 
group). 
In the low-dose and high-dose groups, HR and MAP were significantly de- 
creased from baseline (both, P < 0.05), and these values were significantly lower 
in both groups compared with the control group (all, P < 0.05). Similarly, in the 
low-dose and high-dose groups, Pdi at 20-Hz and 100-Hz stimulation was signifi- 
cantly decreased from baseline (all, P < 0.05), and Edi-cru and Edi-cost at 100-Hz 
stimulation immediately after diazepam infusion were significantly decreased 
from baseline (all, P < 0.05). Also, the decreases in these variables (%Edi-cru 
and %Edi-cost) were significantly greater in the high-dose group compared with 
the low-dose group (both, P < 0.05), which suggests that diazepam causes dia- 
phragmatic dysfunction in a dose-dependent manner. The mechanism by which 
diazepam depresses diaphragmatic contractility with the reduction of electro- 
myographic activity is not known. 
In the present study, HR and MAP immediately after diazepam infusion were 
significantly decreased from baseline (P < 0.05), and returned to near-baseline 
values at 1 hour after the end of infusion. However, the decreased iaphrag- 
matic contractility with reduced electromyographic a tivity did not normalize, 
even 2 hours after the end of infusion. The reason for this finding is unknown, 
but it might be attributable to the difference in the site of action of diazepam 
(cardiovascular system vs diaphragm). 
Based on the MEDLINE search, this is the first study to examine the effects 
of diazepam on diaphragmatic function. However, the following limitations of 
the study should be considered. First, the mechanism by which diazepam 
depresses diaphragmatic contractility with reduced electromyographic a tivity 
was not studied. The selective loss of force at 20-Hz stimulation is closely 
related to the impairment of excitation-contraction coupling, 12 and the selec- 
tive loss of force and electromyographic a tivity at 100-Hz stimulation suggests 
neuromuscular transmission failure. 13,14 Therefore, the decrease in Pdi at both 
levels of stimulation and in Edi at 100-Hz stimulation observed in the low- 
dose and high-dose diazepam groups is presumably due to the impairment of 
excitation-contraction coupling and neuromuscular transmission failure in the 
canine diaphragm. Second, because the author conducted all measurements 
and analyses in this study, he was not blinded to treatment assignment. How- 
ever, despite the lack of a blinded study design, the findings provide important 
information concerning diaphragmatic function during and after diazepam 
administration. 
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CONCLUSION 
The results of this exper imental  study of the effects of d iazepam on diaphrag- 
matic function and recovery in pentobarbita l -anesthet ized dogs suggest that 
d iazepam inhibits d iaphragmatic  function in a dose-related manner  and delays 
recovery. 
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